Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Roche Products Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (79)
Cancellation by sponsor (45)
Australian Public Assessment Report (AusPAR) (40)
Prescription medicine registration (29)
Prescription medicine decision summary (5)
Prescription medicine evaluation (3)

Date

2024 (13)
2023 (22)
2022 (9)
2021 (20)
2020 (16)
2019 (13)
2018 (11)
2017 (19)
2016 (7)
2015 (8)
2014 (5)
2013 (11)
2012 (3)
2011 (5)
2010 (4)
2009 (12)
2008 (2)
2006 (6)
2002 (1)
2000 (3)
1999 (1)
1997 (2)
1994 (2)
1993 (1)
1991 (5)

Results for "[search-keyword]"

Search

Sponsor content

201 result(s) found, displaying 121 to 130

PEGASYS-RBV (peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
PEGASYS-RBV (peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
PEGASYS-RBV (peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
PEGASYS-RBV (peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
PEGASYS-RBV (peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
PEGASYS-RBV (peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
PEGASYS-RBV (peginterferon alfa-2a 135 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
PEGASYS-RBV (peginterferon alfa-2a 180 micrograms/0.5mL injection pre-filled syringe and ribavirin 200mg tablets) Composite pack Cancelled under s30(1)(c)

9 February 2017

Cancellation by sponsor

Requested by Roche Products Pty Ltd
ERIVEDGE vismodegib 150 mg hard capsule bottle (214475)

3 December 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ERIVEDGE vismodegib 150 mg hard capsule bottle.
KADCYLA trastuzumab emtansine (rch) 100 mg powder for injection vial (201621)

3 September 2013

ARTG

Australian Register of Therapeutic Goods (ARTG) information for KADCYLA trastuzumab emtansine (rch) 100 mg powder for injection vial.

Pages

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Page 16
Page 17
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.